BAXTER INTERNATIONAL INC

Baxter International Inc. operates as a global medical products company rooted in the SIC 3841 classification for surgical and medical instruments, delivering infusion systems, renal care, medication delivery tools, and advanced biologic therapies that serve hospitals, outpatient clinics, dialysis centers, and other healthcare institutions worldwide; the company’s suite spans core products such as IV solutions, renal therapy disposables, critical care monitoring, and inpatient nutrition, all backed by a regulatory framework managed under FDA device and biologics controls, evolving reimbursement pressures, and supply-chain scrutiny where compliance lapses or quality recalls can swiftly affect trust and revenue. With a diversified customer base that relies on Baxter for safety-critical applications across acute and chronic treatment settings, it must also navigate global pricing scrutiny, the risk of cyberattacks on clinical systems, and evolving healthcare policies that can ripple through capital allocation decisions; CIK 10456 anchors the filing trail, with the latest public submission noted as pending in this profile. View live SEC filings on Earnings Feed.

Source: Earnings Feed research · last updated 11/24/2025